Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 86603 refers to the laboratory test for antibodies to adenovirus. This test involves analyzing a blood sample to detect the presence of antibodies, which are proteins produced by the immune system in response to an infection. Adenoviruses are a group of viruses that can lead to various illnesses, primarily affecting the respiratory system. Common symptoms associated with adenovirus infections include upper respiratory infections, which may manifest as the common cold, pneumonia, croup, and bronchitis. Additionally, adenoviruses can cause gastroenteritis, conjunctivitis, cystitis, and skin rashes. In some cases, these viruses can lead to acute respiratory disease (ARD). The testing for adenovirus antibodies is typically conducted using enzyme-linked immunosorbent assay (ELISA) methodology, a sensitive and specific technique for detecting antibodies in the blood. The test can measure two types of immunoglobulins: IgG and IgM. IgG testing is utilized to determine if there has been a past or current infection, while IgM testing is specifically aimed at identifying a current infection with a particular adenovirus strain. It is important to note that if both IgG and IgM tests are performed, each test should be reported separately to ensure accurate coding and billing.
© Copyright 2026 Coding Ahead. All rights reserved.
The antibody test for adenovirus (CPT® Code 86603) is indicated for the following conditions:
The procedure for testing antibodies to adenovirus involves several key steps:
Post-procedure care for patients undergoing adenovirus antibody testing is generally minimal, as the blood draw is a routine procedure. Patients may be advised to drink plenty of fluids and to monitor the site of the blood draw for any signs of infection or excessive bruising. Results from the antibody test can take several days to process, and patients should follow up with their healthcare provider to discuss the findings and any necessary next steps based on the results. It is important for healthcare providers to consider the clinical context when interpreting the results, as the presence of antibodies does not always correlate with active disease.
| Short Descr | ADENOVIRUS ANTIBODY | Medium Descr | ANTIBODY ADENOVIRUS | Long Descr | Antibody; adenovirus | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 2 | CCS Clinical Classification | 235 - Other Laboratory |
| 90 | Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number. |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2021-01-01 | Changed | First appearance of guideline addition in code book. |
| 2020-04-10 | Changed | AMA Guideline added |
| 1993-01-01 | Added | First appearance in code book in 1993. |
Get instant expert-level medical coding assistance.